Skin and soft tissue infections (SSIs) are one of the many infectious disea
ses that can be treated by outpatient parenteral antiinfective therapy (OPA
T). Determining whether a patient with SSIs is treated topically, orally, o
r parenterally depends on the severity of infection and host factors. The d
ecision to hospitalize, initiate, or transition to OPAT with SSIs depends o
n the medical assessment and consideration of available resources for OPAT.
Anti-infective selection depends on the clinical presentation, likely orga
nisms, pharmacodynamics, pharmacokinetics, and drug stability.